2025 Spring Registration Brochure

Registration Brochure 5 SESSION 1.1.................................................................. 9:15 AM - 10:15 AM Number and Type of Credits: Clinical Addiction Neurobiology and the Opioid Epidemic, Course #6170, is approved by the Association of Social Work Boards (ASWB). Approved Continuing Education (ACE) program to be offered by the New Jersey Association of Mental Health and Addiction Agencies (NJAMHAA) as an individual course. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE course approval period: 2/20/2025 - 2/20/2027. Social workers completing this course will receive 1 clinical continuing education credit. This course is approved by the NJ Association of Mental Health and Addiction Agencies (NJAMHAA), as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #87719, NJAMHAA is responsible for all aspects of the programming. Petros Levounis, MD, MA Professor and Chair, Department of Psychiatry; Associate Dean Rutgers New Jersey Medical School COURSE DESCRIPTION: From a neurobiological perspective, addiction is the hijacking of the pleasure-reward pathways of the brain and a weakening of its executive function. In 2025, the fundamental model has been expanded to include newer concepts such as motivational circuitry, the anti-reward pathways, and interoception. These 21st century discoveries inform clinical innovations that are revolutionizing the landscape of the pharmacological and psychosocial treatments of substance use disorders, especially opioid use disorder, and the behavioral addictions. Learning Objectives: At the end of this session, attendees will be able to: 1. Explain the basic elements of drive and cognition in the neurobiology of addiction. 2. Describe the role of the insula in the 2025 model of addiction. 3. Discuss clinical implications of the neurobiology of addiction in treating substance use disorders, especially opioid use disorder, and the behavioral addictions. Target Audience: All Healthcare Providers Audience Target Levels: Intermediate Keynote Address DAY 1 | APRIL 8, 2025 Addiction, Neurobiology and the Opioid Epidemic